OpenAlex
PricingAboutJobs
Log inGet started
Work

Hydrochlorothiazide, but not Candesartan, Aggravates Insulin Resistance and Causes Visceral and Hepatic Fat Accumulation: The Mechanisms for the Diabetes Preventing Effect of Candesartan (MEDICA) Study

HTML

Year: 2008
Type: article
Study design: Clinical Trial
Source: Hypertension
DOI: 10.1161/hypertensionaha.108.119404
Authors: Jan W. Eriksson, Per-Anders Jansson, Bo Carlberg, Anders Hägg, Lisa Kurland, Maria K. Svensson, Håkan Ahlström, Conny Ström, Lars Lönn, Kristina Öjbrandt, Lars Johansson, Lars Lind
Institutions: Sahlgrenska University Hospital, University Hospital of Umeå, AstraZeneca (Sweden), Uppsala University Hospital
Language: English

Topic: Blood Pressure and Hypertension Studies
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: hydrochlorothiazide, candesartan, insulin resistance, visceral fat, hepatic lipid accumulation, thiazide diuretics, angiotensin receptor blockers, type 2 diabetes prevention, abdominal obesity, hepatic steatosis, subcutaneous adipose tissue, low-grade inflammation, C-reactive protein, insulin sensitivity, first-phase insulin secretion, intramyocellular lipid
SDG: Good health and well-being

Open Access status: closed

Funders: AstraZeneca, Vetenskapsrådet
OpenAlex ID: W2168493982
FWCI: 9.377
Cites: 48
Cited by: 148
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security